Nistered to clients with RA. When some medical improvement was noted in open-labelled scientific tests, placebo-controlled trials observed no statistically considerable improvement in collagen-fed clients, like among patients with early RA [30,46-48]. Oral human gp39 was also trialled by two firms, but with very little evidence of efficacy [49]. Oral lyophilised E. coli extract incorporates…